AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Impact of Footwear on Gait in Unilateral Transtibial Amputees

RecruitingNAAges 18 Years - 65 YearsAllUniversity of Salford
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this interventional study is to learn how different types of footwear affect gait, stability, comfort, and walking performance in adults with a unilateral transtibial amputation who use a lower limb prosthesis. The main questions it aims to answer are: * Does footwear type affect gait characteristics such as gait speed, stride length, cadence, prosthetic foot clearance, and stance phase duration? * Does footwear type affect kinetic measures such as ground reaction forces and ankle power variables during walking? * Does footwear type affect in-shoe plantar pressure distribution? * Do participants perceive differences in comfort and stability between footwear conditions? Participants will: * Attend a laboratory-based gait analysis session at the University of Salford. * Complete walking tasks while wearing four footwear conditions: their own preferred footwear, an Oxford sh

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Individuals with a unilateral transtibial amputation. * Age 18 to 65 years. * Participants must use an energy-storing and return (ESAR) prosthetic foot. * Able to walk and stand without the use of walking aids. * Absence of comorbidities known to impact balance and mobility. Exclusion Criteria: * Bilateral amputees or individuals with amputation levels other than transtibial. * Individuals under 18 years or over 65 years of age. * Use of any prosthetic foot type other than ESAR. * Individuals unable to provide informed consent.
๐Ÿ’Š

What it tests

  • Own Footwear
  • Oxford Shoe
  • Walking/Running Shoe
  • Rocker Shoe
๐Ÿ“

Where

1 site
University of Salford
Manchester, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy